Oncology
-
Blogger Spotlight: ONC’s Response to ASCO 2017
[vc_row][vc_column][vc_column_text]Even though ASCO 2017 wrapped up over a month ago, we are still pretty curious and interested in what’s to come from the oncology community. We’re especially excited to hear what real attendees have to say about their experiences. Our curiosity sparked us to reach out to one of our Oncologists who went to ASCO…
-
Trends in Oncology: Metaphor Basics
[vc_row][vc_column][vc_column_text]The treatment discussion as a whole has been impacted by the launch of new classes of treatment and new products over the past year. One third (10/30) of newly approved molecules in the European Union in 2016 were drugs for use in oncology. As we continue our look at trends across Verilogue’s conversation database, one…
-
Trends in Oncology: Conversation “Vital Signs”
[vc_row][vc_column][vc_column_text]As we convened with our global oncology colleagues and look toward the future of cancer research at ASCO 2017, Verilogue analysts have taken a last look at 2016 to see how two basic conversation “vital signs” have evolved in the European (and UK) oncology visit.
-
ONCs’ Top Tips for Attending ASCO 2017
[vc_row][vc_column][vc_column_text]Every year marketers, HCPs, and researchers gather at ASCO (American Society of Clinical Oncology) to learn about the newest breakthroughs and developments in the war on cancer. With a large variety of progress across all cancer types, this conference is a great opportunity for individuals to stay on top of industry news. With a lot…